Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 4, 2023

Details for New Drug Application (NDA): 205919

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 205919 describes PURIXAN, which is a drug marketed by Nova Labs Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the PURIXAN profile page.

The generic ingredient in PURIXAN is mercaptopurine. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mercaptopurine profile page.
Summary for 205919
Applicant:Nova Labs Ltd
Formulation / Manufacturing:see details
Pharmacology for NDA: 205919
Suppliers and Packaging for NDA: 205919
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PURIXAN mercaptopurine SUSPENSION;ORAL 205919 NDA Nova Laboratories, Ltd 62484-0020 62484-0020-2 1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength20MG/ML
Approval Date:Apr 28, 2014TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.